🏅 FDA Orphan Designation

Mitosol

mitomycin-C

Manufacturer: Glaukos Corporation

Indicated for:

Congenital malformation of the eye with glaucoma as a major featureOrphan

FDA-Approved Indications (1)

Congenital malformation of the eye with glaucoma as a major featureOrphan Designation

An adjunct to ab externo glaucoma surgery.

Indications & Usage

1 INDICATIONS AND USAGE Mitosol ® is an antimetabolite indicated for use as an adjunct to ab externo glaucoma surgery. Mitosol ® is an antimetabolite indicated as an adjunct to ab externo glaucoma surgery. ( 1 )

💙 Support Programs

View all →

Mitosol

Glaukos Corporation

Where shown, WAC (Wholesale Acquisition Cost) is an estimate only — your actual cost depends on your insurance plan. Always verify pricing with your pharmacy or insurer.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.